Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004961891 | SCV005468774 | uncertain significance | Inborn genetic diseases | 2024-12-10 | criteria provided, single submitter | clinical testing | The c.5620T>G (p.W1874G) alteration is located in exon 15 (coding exon 15) of the PKD1 gene. This alteration results from a T to G substitution at nucleotide position 5620, causing the tryptophan (W) at amino acid position 1874 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005006583 | SCV005643486 | uncertain significance | Polycystic kidney disease, adult type | 2024-01-05 | criteria provided, single submitter | clinical testing |